THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA.
Saved in:
| Title: | THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA. |
|---|---|
| Authors: | Spriano, F., Chung, E., Napoli, S., Tarantelli, C., Gaudio, E., Cascione, L., Cavalli, A., Rinaldi, A., Kwee, I., Ye, H., Rossi, D., Zucca, E., Stathis, A., Jessen, K., Lannutti, B., Toretsky, J., Bertoni, F. |
| Source: | Hematological oncology Jun2019 Supplement S2; Vol. 37. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
